Golden State Wealth Management LLC Increases Stock Position in CVS Health Corporation (NYSE:CVS)

Golden State Wealth Management LLC lifted its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 5,096.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,949 shares of the pharmacy operator's stock after purchasing an additional 3,873 shares during the period. Golden State Wealth Management LLC's holdings in CVS Health were worth $268,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Hopwood Financial Services Inc. bought a new position in CVS Health in the 4th quarter worth $29,000. McIlrath & Eck LLC boosted its stake in shares of CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the period. Providence First Trust Co purchased a new stake in shares of CVS Health during the fourth quarter worth about $42,000. Park Square Financial Group LLC bought a new stake in CVS Health during the 4th quarter valued at approximately $43,000. Finally, PARK CIRCLE Co lifted its holdings in CVS Health by 42.9% in the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock worth $45,000 after purchasing an additional 300 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Up 0.5%

CVS Health stock traded up $0.36 during mid-day trading on Friday, hitting $68.50. The company's stock had a trading volume of 5,937,044 shares, compared to its average volume of 10,854,461. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The stock has a market cap of $86.66 billion, a PE ratio of 16.35, a P/E/G ratio of 0.98 and a beta of 0.56. The company has a 50 day moving average of $64.86 and a 200-day moving average of $60.86. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.31 EPS. On average, research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on CVS shares. Royal Bank Of Canada raised their target price on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Cowen reiterated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Barclays set a $79.00 target price on shares of CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. UBS Group increased their price target on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Finally, Mizuho boosted their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $74.75.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director now directly owns 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is owned by company insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.